Autoimmune Market Research Reports & Industry Analysis
Classification of autoimmune disorders is still somewhat controversial, but the following criteria is generally accepted: Direct evidence from transfer of pathogenic antibody or pathogenic T cells, indirect evidence based on reproduction of the autoimmune disease in experimental animals, and circumstantial evidence from clinical clues
Arthritis is among the most common autoimmune disorders. Arthritis is joint inflammation The major complaint by individuals who have arthritis is joint pain. Pain is often a constant and may be localized to the joint affected. There are over one hundred forms different forms The most common form, osteoarthritis (degenerative joint disease) is a result of trauma to the joint, infection of the joint, or age. Other arthritis forms are rheumatoid arthritis, psoriatic arthritis, and related autoimmune diseases. Septic arthritis is caused by joint infection. Treatment options vary depending on the type of arthritis and include physical therapy, exercise and weight control, bracing, medications. Surgery may be required in some changes.
Autoimmune Industry Research & Market Reports
-
Global Nucleic Acid Therapeutics Market Size study, by Product (Anti-Sense Oligonucleotides (ASO), RNA Interference (RNAi), RNA Aptamers), by Indication (Autoimmune Disorders, Infectious Diseases, Genetic Disorders, Cancer, Others), by End-user (Hospitals, Physicians’ Offices, Others), and Regional Forecasts 2022-2032
... Forecasts 2022-2032 The Global Nucleic Acid Therapeutics Market was valued at approximately USD 6.0 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 12.8% over the forecast period ... Read More
-
U.S. IVD And LDT For Autoimmune Diseases Market Size, Share & Trends Analysis Report By Type (IVD, LDT), By Technology (Immunoassays, Clinical Chemistry, Hematology, Coagulation, Microbiology), By Application, By Country, And Segment Forecasts, 2024 - 203
... 2030 U.S. IVD And LDT For Autoimmune Diseases Market Growth & Trends The U.S. IVD and LDT for autoimmune diseases market size is expected to reach USD 3.70 billion by 2030, growing at a CAGR ... Read More
-
Global Immunology Market 2024-2028
... immunology market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market scenario, ... Read More
-
Biologics Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Monooclonal Antibodies, Vaccines, Recombinant Hormones/Proteins, Cell and Gene Therapy, and Others), Application (Cancer, Infectius Diseases, Autoimmune Diseases, and Others), Source (Mammalian and Microbial), Manufacturing (Outsourced and In-house), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
... Diseases, Autoimmune Diseases, and Others), Source (Mammalian and Microbial), Manufacturing (Outsourced and In-house), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America) According to our new research study ... Read More
-
Global mRNA Vaccines and Therapeutics Market Size Study, by Vaccine Type (Self-amplifying mRNA-based Vaccines, Conventional Non-amplifying mRNA-based Vaccines), by Application (Cancer, Infectious Diseases, Autoimmune Diseases, Other Applications), by Treatment Type (Monoclonal Antibody, Gene Therapy, Cell Therapy, Other Treatment Types), by End User (Research Laboratories and Organizations, Hospitals and Clinics, Other End Users) and Regional Forecasts 2022-2032
... Therapy, Other Treatment Types), by End User (Research Laboratories and Organizations, Hospitals and Clinics, Other End Users) and Regional Forecasts 2022-2032 Global mRNA Vaccines and Therapeutics Market is valued at approximately USD 46.8 billion in ... Read More
-
Global Pemphigus Vulgaris Treatment Market - 2024-2031
... during the forecast period 2024-2031. Pemphigus vulgaris is a rare group of autoimmune diseases. It causes blisters on the skin and mucous membranes throughout the body. It can affect the mouth, nose, throat, eyes, and ... Read More
-
Veterinary Autoimmune Disease Therapeutics Global Market Report 2024
... Disease; Canine Lupus; Auto-Immune Hemolytic Anemia; Bullous Pemphigoid; Discoid Lupus Erythematosus (DLE); Immune-Related Arthritis4) By Distribution Channel: Veterinary Hospitals; Veterinary ClinicsCovering: Pfizer Inc; Merck & Co Inc; AbbVie Inc.; Sanofi S.A.; Novartis AG Veterinary Autoimmune ... Read More
-
Europe In-Vitro Diagnostics Market Forecast Report by Test Types (ELISA & CLIA, PCR, Rapid Test, Fluorescence Immunoassays (FIA), In Situ Hybridization, Transcription Mediated Amplification, Sequencing, Colorimetric Immunoassay, Radioimmunoassay (RIA), Isothermal Nucleic Acid Amplification Technology, Others) Product (Services, Instruments, Reagents) Application (Infectious Disease, Diabetes, Cardiology, Oncology, Nephrology, Autoimmune Diseases, Drug Testing, Other Applications) Technology (Immunoassay, Clinical Chemistry, Molecular Diagnostics/Genetics, Hematology, Microbiology, Coagulation, Others) End User (Hospitals, Laboratories, Home - Care, Others) Countries and Company Analysis, 2024-2032
... Product (Services, Instruments, Reagents) Application (Infectious Disease, Diabetes, Cardiology, Oncology, Nephrology, Autoimmune Diseases, Drug Testing, Other Applications) Technology (Immunoassay, Clinical Chemistry, Molecular Diagnostics/Genetics, Hematology, Microbiology, Coagulation, Others) End User (Hospitals, Laboratories, Home - Care, Others) ... Read More
-
Autoimmune Disease Diagnosis
... by 2030, growing at a CAGR of 5.3% over the period 2023-2030. Consumables & Assay Kits, one of the segments analyzed in the report, is expected to record 5.6% CAGR and reach US$4.1 Billion by ... Read More
-
Autoimmune Hepatitis - Pipeline Insight, 2024
... including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global ... Read More
-
Warm Autoimmune Hemolytic Anemia (WAIHA) - Market Insight, Epidemiology And Market Forecast - 2034
... most common type of autoimmune hemolytic anemia, comprising nearly 70–80% of all adult cases and 50% of pediatric cases. wAIHA can develop at any age, but the median age of onset is 52 years. The ... Read More
-
Sjogren's Syndrome - Market Insight, Epidemiology And Market Forecast - 2034
... and lacrimal glands. It can be classified into two types, i.e., primary Sjogren’s syndrome and secondary Sjogren’s syndrome. Primary Sjogren’s syndrome (pSS) occurs in the absence of other autoimmune diseases and is characterized by keratoconjunctiva ... Read More
-
Italy In-Vitro Diagnostics Market Forecast Report by Test Types (ELISA & CLIA, PCR, Rapid Test, Fluorescence Immunoassays (FIA), In Situ Hybridization, Transcription Mediated Amplification, Sequencing, Colorimetric Immunoassay, Radioimmunoassay (RIA), Isothermal Nucleic Acid Amplification Technology, Others) Products (Services, Instruments, Reagents) Technology (Immunoassay, Clinical Chemistry, Molecular Diagnostics/Genetics, Haematology, Microbiology, Coagulation, Others) Application (Infectious Disease, Diabetes, Cardiology, Oncology, Nephrology, Autoimmune Diseases, Drug Testing, Other Applications) End User (Hospitals, Laboratories, Home - Care, Others) and Company Analysis, 2024-2032
... Products (Services, Instruments, Reagents) Technology (Immunoassay, Clinical Chemistry, Molecular Diagnostics/Genetics, Haematology, Microbiology, Coagulation, Others) Application (Infectious Disease, Diabetes, Cardiology, Oncology, Nephrology, Autoimmune Diseases, Drug Testing, Other Applications) End User (Hospitals, Laboratories, Home - Care, Others) ... Read More
-
Global Sjogrens Syndrome Therapeutics Market 2024-2028
... sjogrens syndrome therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current ... Read More
-
Mexico In-Vitro Diagnostics (IVD) Market, By Technique (Clinical Chemistry, Molecular Diagnostics, Immuno Diagnostics, Hematology, Other), By Product (Instrument, Reagent, Other), By Usability (Disposable IVD Devices, Reusable IVD Devices), By Application (Infectious Disease, Cancer/Oncology, Cardiology, Autoimmune Disease, Diabetes, Nephrology, Other), By End User (Diagnostic Laboratories, Hospitals and Clinics, Other), By Region, Competition, Forecast & Opportunities, 2019-2029F
... Disease, Diabetes, Nephrology, Other), By End User (Diagnostic Laboratories, Hospitals and Clinics, Other), By Region, Competition, Forecast & Opportunities, 2019-2029F Mexico In-Vitro Diagnostics (IVD) Market was valued at USD 1.20 billion in 2023 and is ... Read More
-
Global Autoimmune Drugs Market 2024-2028
... report on the autoimmune drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding ... Read More
-
Immunotherapy Drugs Market Size, Share & Trends by Type (mAb, Checkpoint Inhibitor, Interferon, Cancer Vaccine), Application (Cancer, Autoimmune, Inflammatory, Hematology, Neurology), Route of Administration (Intravenous, Subcutaneous), End User - Global Forecast to 2029
... are designed to enhance the immune response or modulate the immune system's regulatory mechanisms, thereby enabling the body to effectively target and eliminate disease-causing agents or cellsThe immunotherapy drugs market is projected to grow from ... Read More
-
Nucleic Acid Therapeutics Market [Product: Anti-Sense Oligonucleotides (ASO), RNA Interference (RNAi), and RNA Aptamers; and Indication: Autoimmune Disorders, Infectious Diseases, Genetic Disorders, Cancer, and Others] - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034
... 2024-2034 Nucleic Acid Therapeutics Market – Scope of Report TMR’s report on the global nucleic acid therapeutics market studies the past as well as the current growth trends and opportunities to gain valuable insights of ... Read More
-
Stem Cells Market Analysis and Forecast to 2033 : By TYPE (Embryonic, Hematopoietic, Mesenchymal, Neural, Epithelial, Induced Pluripotent), SOURCE (Bone Marrow-Derived, Adipose Tissue-Derived, Umbilical Cord Blood, Dental Pulp-Derived, Amniotic Fluid-Derived), THERAPY (Autologus, Allogenic, Syngeneic), TECHNOLOGY (Cell Production, Cell Acquisition, Expansion and Sub-Culture, Wounds & Injuries, Cryopreservation), APPLICATION (Regenerative Medicine, Drug Discovery and Development, Tissue Engineering and Regeneration, Cell-Based Therapies, Research Applications, Toxicology Studies), THERAPEUTIC AREAS (Oncology, Orthopedics and Musculoskeletal Disorders, Cardiovascular Diseases, Neurological Disorders, Autoimmune Disorders, Diabetes, Wound Healing and Dermatology, Ophthalmology, Liver Diseases, Renal Diseases), END USERS (Hospitals and Clinics, Research Institutes and Academic Centers, Biotechnology and Pharmaceutical Companies, Contract Research Organizations, Stem Cell Banks and Storage
... (Cell Production, Cell Acquisition, Expansion and Sub-Culture, Wounds & Injuries, Cryopreservation), APPLICATION (Regenerative Medicine, Drug Discovery and Development, Tissue Engineering and Regeneration, Cell-Based Therapies, Research Applications, Toxicology Studies), THERAPEUTIC AREAS (Oncology, Orthopedics and Musculoskeletal Disorders, ... Read More
-
IVD Quality Control Market Assessment, By Source [Plasma, Whole Blood, Urine], By Product [Quality Control Products, Data Management Solutions, Quality Assessment Services], By Application [Oncology, Cardiology, Neurology, Infectious Diseases, Autoimmune Disorders, Others], By Technique [Molecular Diagnostics, Coagulation/Hemostasis, Hematology, Microbiology, Immunochemistry/Immunoassay, Clinical Chemistry/Biochemistry, Others], By End-user [Hospitals and Clinics, Diagnostic Laboratories, IVD Manufacturers, CROs, Others], By Region, Opportunities and Forecast, 2017-2031F
... Diagnostics, Coagulation/Hemostasis, Hematology, Microbiology, Immunochemistry/Immunoassay, Clinical Chemistry/Biochemistry, Others], By End-user [Hospitals and Clinics, Diagnostic Laboratories, IVD Manufacturers, CROs, Others], By Region, Opportunities and Forecast, 2017-2031F Global IVD quality control market is projected to witness a ... Read More
-
Nucleic Acid Therapeutics Market (Product Type: RNA interference (RNAi) and Short Interfering RNAs, Antisense Oligonucleotides (ASOs), and Others; and Application: Autoimmune Disorders, Infectious Diseases, Genetic Disorders, Cancer, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034
... Growth, Trends, and Forecast, 2024-2034 Nucleic Acid Therapeutics Market – Scope of Report TMR’s report on the global nucleic acid therapeutics market studies the past as well as the current growth trends and opportunities to ... Read More
-
Global Autologous Cell Therapy Market Size Study, by Application (Cancer, Neurodegenerative Disorders, Cardiovascular Disorders, Autoimmune Disorders, Orthopedics, Wound Healing, Others), by Source (Bone Marrow, Peripheral Blood, Adipose Tissue, Others), by End-Use (Hospitals, Academics & Research, Others), and Regional Forecasts 2022-2032
... Others), and Regional Forecasts 2022-2032 The Global Autologous Cell Therapy Market is valued approximately at USD 4.32 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 22.20% over ... Read More
-
IVD Contract Research Organization Market - forecast to 2033 : By SERVICE TYPE (Clinical Chemistry, Immunochemistry, Hematology, Histology and Cytology, Microbiology, Molecular Diagnostics, Genetic Testing, Others), THERAPEUTIC AREA (Oncology, Infectious Diseases, Cardiovascular Diseases, Neurological Disorders, Autoimmune Disorders, Metabolic Diseases, Others), END USER (Hospitals, Diagnostic Laboratories, Academic and Research Institutes, Pharmaceutical, Biotechnology, Others), PHASE OF DEVELOPMENT (Preclinical, Clinical Phase I, Clinical Phase II, Clinical Phase III, Post-market Surveillance), PRODUCT TYPE (Reagents & Kits, Instruments, Services, Software), TECHNOLOGY (Polymerase Chain Reaction, Enzyme-Linked Immunosorbent Assay, Mass Spectrometry, Next-Generation Sequencing, Microarrays, Flow Cytometry, Others), APPLICATION (Infectious Disease Testing, Cancer Diagnosis, Cardiovascular Disease Testing, Diabetes Testing, Autoimmune Disease Testing, Blood Screening, Others), TYPE OF S
... Autoimmune Disorders, Metabolic Diseases, Others), END USER (Hospitals, Diagnostic Laboratories, Academic and Research Institutes, Pharmaceutical, Biotechnology, Others), PHASE OF DEVELOPMENT (Preclinical, Clinical Phase I, Clinical Phase II, Clinical Phase III, Post-market Surveillance), PRODUCT TYPE (Reagents ... Read More
-
Intravenous Immunoglobulin (IVIg)
... by 2030, growing at a CAGR of 8.6% over the analysis period 2023-2030. IgA, one of the segments analyzed in the report, is expected to record a 10.7% CAGR and reach US$13.7 Billion by the ... Read More
-
Autoimmune Disease Therapeutics
... by 2030, growing at a CAGR of 3.8% over the analysis period 2023-2030. Anti-inflammatory Drug Class, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$183.0 Billion ... Read More
Research Assistance
